Surmodics EBITDA Margin 2010-2023 | SRDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surmodics (SRDX) over the last 10 years. The current EBITDA margin for Surmodics as of December 31, 2023 is .
| Surmodics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $0.14B | $0.02B | 15.94% |
| 2023-09-30 | $0.13B | $0.02B | 11.36% |
| 2023-06-30 | $0.13B | $0.01B | 8.46% |
| 2023-03-31 | $0.10B | $-0.02B | -17.48% |
| 2022-12-31 | $0.10B | $-0.02B | -16.67% |
| 2022-09-30 | $0.10B | $-0.01B | -13.00% |
| 2022-06-30 | $0.10B | $-0.01B | -7.14% |
| 2022-03-31 | $0.10B | $-0.00B | -3.09% |
| 2021-12-31 | $0.11B | $0.01B | 10.38% |
| 2021-09-30 | $0.11B | $0.01B | 13.33% |
| 2021-06-30 | $0.10B | $0.01B | 11.54% |
| 2021-03-31 | $0.11B | $0.02B | 14.95% |
| 2020-12-31 | $0.10B | $0.01B | 7.37% |
| 2020-09-30 | $0.10B | $0.01B | 7.29% |
| 2020-06-30 | $0.10B | $0.01B | 12.50% |
| 2020-03-31 | $0.10B | $0.01B | 12.87% |
| 2019-12-31 | $0.10B | $0.01B | 13.86% |
| 2019-09-30 | $0.10B | $0.01B | 14.00% |
| 2019-06-30 | $0.09B | $0.01B | 7.61% |
| 2019-03-31 | $0.09B | $-0.00B | -1.11% |
| 2018-12-31 | $0.09B | $-0.00B | -2.33% |
| 2018-09-30 | $0.08B | $-0.00B | -3.70% |
| 2018-06-30 | $0.08B | 0 | 0.00% |
| 2018-03-31 | $0.07B | $0.01B | 10.81% |
| 2017-12-31 | $0.07B | $0.01B | 12.33% |
| 2017-09-30 | $0.07B | $0.01B | 17.57% |
| 2017-06-30 | $0.07B | $0.02B | 22.22% |
| 2017-03-31 | $0.07B | $0.02B | 28.38% |
| 2016-12-31 | $0.07B | $0.02B | 30.14% |
| 2016-09-30 | $0.07B | $0.02B | 30.56% |
| 2016-06-30 | $0.07B | $0.02B | 30.99% |
| 2016-03-31 | $0.07B | $0.02B | 31.34% |
| 2015-12-31 | $0.06B | $0.02B | 34.38% |
| 2015-09-30 | $0.06B | $0.02B | 37.70% |
| 2015-06-30 | $0.06B | $0.02B | 40.68% |
| 2015-03-31 | $0.06B | $0.02B | 39.66% |
| 2014-12-31 | $0.06B | $0.02B | 37.93% |
| 2014-09-30 | $0.06B | $0.02B | 36.21% |
| 2014-06-30 | $0.06B | $0.02B | 36.84% |
| 2014-03-31 | $0.06B | $0.02B | 35.71% |
| 2013-12-31 | $0.06B | $0.02B | 37.50% |
| 2013-09-30 | $0.06B | $0.02B | 39.29% |
| 2013-06-30 | $0.06B | $0.02B | 37.50% |
| 2013-03-31 | $0.06B | $0.02B | 39.29% |
| 2012-12-31 | $0.05B | $0.02B | 38.89% |
| 2012-09-30 | $0.05B | $0.02B | 36.54% |
| 2012-06-30 | $0.05B | $0.02B | 34.62% |
| 2012-03-31 | $0.05B | $0.02B | 33.33% |
| 2011-12-31 | $0.05B | $0.02B | 34.62% |
| 2011-09-30 | $0.05B | $0.02B | 35.85% |
| 2011-06-30 | $0.06B | $-0.00B | -9.09% |
| 2011-03-31 | $0.06B | $-0.01B | -9.84% |
| 2010-12-31 | $0.07B | $-0.01B | -15.15% |
| 2010-09-30 | $0.07B | $-0.01B | -14.29% |
| 2010-06-30 | $0.07B | $0.02B | 21.92% |
| 2010-03-31 | $0.07B | $0.02B | 25.00% |
| 2009-12-31 | $0.08B | $0.03B | 33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.376B | $0.133B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
| Stryker (SYK) | United States | $124.585B | 30.89 |
| Medtronic (MDT) | Ireland | $105.150B | 14.89 |
| Boston Scientific (BSX) | United States | $98.912B | 32.89 |
| EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
| ResMed (RMD) | United States | $26.124B | 26.12 |
| Terumo (TRUMY) | Japan | $24.607B | 34.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
| Baxter (BAX) | United States | $20.135B | 14.69 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.535B | 60.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
| Demant (WILYY) | Denmark | $9.782B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.014B | 23.88 |
| BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
| Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
| Haemonetics (HAE) | United States | $4.239B | 21.68 |
| Perrigo (PRGO) | Ireland | $4.057B | 11.60 |
| GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
| Envista Holdings (NVST) | United States | $3.394B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
| Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
| Neogen (NEOG) | United States | $2.584B | 24.85 |
| QuidelOrtho (QDEL) | United States | $2.559B | 9.29 |
| ICU Medical (ICUI) | United States | $2.361B | 17.62 |
| TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
| Owens & Minor (OMI) | United States | $1.843B | 17.69 |
| Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
| InMode (INMD) | Israel | $1.456B | 7.54 |
| LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
| AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
| Warby Parker (WRBY) | United States | $1.169B | 0.00 |
| AtriCure (ATRC) | United States | $1.131B | 0.00 |
| MacroGenics (MGNX) | United States | $1.005B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
| Evolus (EOLS) | United States | $0.670B | 0.00 |
| Jin Medical (ZJYL) | China | $0.617B | 0.00 |
| Quanterix (QTRX) | United States | $0.604B | 0.00 |
| Valneva SE (VALN) | France | $0.565B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
| TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
| PetIQ (PETQ) | United States | $0.472B | 17.61 |
| ZimVie (ZIMV) | United States | $0.427B | 26.13 |
| Biote (BTMD) | United States | $0.405B | 3.86 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.368B | 42.41 |
| Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| InterCure (INCR) | Israel | $0.118B | 19.92 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.104B | 0.00 |
| Safety Shot (SHOT) | United States | $0.099B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |